We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Filtration System Removes Prions

By Biotechdaily staff writers
Posted on 16 Jun 2004
A new filtration system for removing prions and infectious and self-replicating proteins from biologic fluids has been developed.

The new filter technology, which was developed by Pall Corporation (East Hills, NY, USA), removes prions to below the level of detection by both Western Blot assays and infectivity studies from scrapie-infected red blood cell concentrates. More...

In the biologic laboratory, the new filters will have immediate application for the removal of prions from the animal growth factors and sera used in tissue culture procedures. Another potential application may be found in the filtration of serum before use in transfusions. The new technology will complement the Pall Ultipor 25 Breathing System Filter, used in anesthesia and respiratory procedures, which has been validated as a prion transmission barrier.

Dr. Jerold Martin, global technical director of Pall Corporation, said, "Although biotech companies are striving to develop protein-based therapies that are serum-free, the reality is that many products currently use bovine serum-supplemented culture media. As concerns grow about the potential for BSE contamination, membrane filtration technology is increasingly being recognized and used as an effective method to remove prions to significantly reduce the risk of BSE contamination.”



Related Links:
Pall Corporation

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Thyroid Test
Anti-Thyroid EIA Test
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.